BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2563969)

  • 1. Narcotic analgesics, their detection and pain measurement in the horse: a review.
    Kamerling S; Wood T; DeQuick D; Weckman TJ; Tai C; Blake JW; Tobin T
    Equine Vet J; 1989 Jan; 21(1):4-12. PubMed ID: 2563969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose related effects of the kappa agonist U-50, 488H on behaviour, nociception and autonomic response in the horse.
    Kamerling S; Weckman T; Donahoe J; Tobin T
    Equine Vet J; 1988 Mar; 20(2):114-8. PubMed ID: 3286243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
    Zimmerman DM; Leander JD; Reel JK; Hynes MD
    J Pharmacol Exp Ther; 1987 May; 241(2):374-8. PubMed ID: 3033213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the interaction of mu and kappa opioid agonists on locomotor behavior in the horse.
    Mama KR; Pascoe PJ; Steffey EP
    Can J Vet Res; 1993 Apr; 57(2):106-9. PubMed ID: 8490803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mu, but not kappa, opioid agonists induce contractions of the canine small intestine ex vivo.
    Hirning LD; Porreca F; Burks TF
    Eur J Pharmacol; 1985 Feb; 109(1):49-54. PubMed ID: 2986990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of morphine in rats treated chronically with U-50,488 H, a kappa opioid receptor agonist.
    Bhargava HN; Ramarao P; Gulati A
    Eur J Pharmacol; 1989 Mar; 162(2):257-64. PubMed ID: 2542058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-related effects of ethylketazocine on nociception, behaviour and autonomic responses in the horse.
    Kamerling SG; Dequick DJ; Weckman TJ; Tobin T
    J Pharm Pharmacol; 1986 Jan; 38(1):40-5. PubMed ID: 2869125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of morphine, ethylketocyclazocine, U-50,488H and naloxone on the acquisition of a classically conditioned response in the rabbit.
    Schindler CW; Gormezano I; Harvey JA
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1010-7. PubMed ID: 3320342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1990 Mar; 252(3):945-52. PubMed ID: 1969478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.
    Takemori AE; Ho BY; Naeseth JS; Portoghese PS
    J Pharmacol Exp Ther; 1988 Jul; 246(1):255-8. PubMed ID: 2839664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endorphins and food intake: kappa opioid receptor agonists and hyperphagia.
    Cooper SJ; Jackson A; Kirkham TC
    Pharmacol Biochem Behav; 1985 Nov; 23(5):889-901. PubMed ID: 2867562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat.
    Locke KW; Gorney B; Cornfeldt M; Fielding S
    Psychopharmacology (Berl); 1989; 99(4):492-6. PubMed ID: 2556726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu- and kappa-opiate agonists modulate ingestive behaviors in the slug, Limax maximus.
    Kavaliers M; Rangeley RW; Hirst M; Teskey GC
    Pharmacol Biochem Behav; 1986 Mar; 24(3):561-6. PubMed ID: 3010335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of activity of kappa receptor agonists in the rabbit vas deferens.
    Hayes A; Kelly A
    Eur J Pharmacol; 1985 Apr; 110(3):317-22. PubMed ID: 2988982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptor agonists in the rabbit colon: comparison of in vivo and in vitro studies.
    Pairet M; Ruckebusch Y
    Life Sci; 1984 Oct; 35(16):1653-8. PubMed ID: 6148681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential cross-tolerance to opioid agonists in morphine-tolerant pigeons responding under a schedule of food presentation.
    Craft RM; Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):386-93. PubMed ID: 2542528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.